Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy–Experienced Patients with HIV Infection in North America
Author(s) -
Steven G. Deeks,
Stephen J. Gange,
Mari M. Kitahata,
Michael S. Saag,
Amy C. Justice,
Robert S. Hogg,
Joseph J. Eron,
John T. Brooks,
Sean B. Rourke,
M. John Gill,
Ronald J. Bosch,
Constance A. Benson,
Ann C. Collier,
Jeffrey N. Martin,
Marina B. Klein,
Lisa P. Jacobson,
Benigno Rodríguez,
Timothy R. Sterling,
Gregory D. Kirk,
Sonia Napravnik,
Anita Rachlis,
Liviana Calzavara,
Michael A. Horberg,
Michael J. Silverberg,
Kelly A. Gebo,
Margot Kushel,
James J. Goedert,
Rosemary G. McKaig,
Richard D. Moore
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/644768
Subject(s) - medicine , regimen , proportional hazards model , viral load , mortality rate , antiretroviral therapy , immunology , human immunodeficiency virus (hiv)
Although combination antiretroviral therapy continues to evolve, with potentially more effective options emerging each year, the ability of therapy to prevent multiple regimen failure and mortality in clinical practice remains poorly defined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom